| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/06/1999 | EP0912191A1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 05/06/1999 | EP0912181A1 Appetite suppression |
| 05/06/1999 | DE19748195A1 Disaccharidderivate zur Behandlung von Hyperglykämien Disaccharide derivatives for the treatment of hyperglycaemia |
| 05/06/1999 | CA2308705A1 Aggregates of human insulin derivatives |
| 05/06/1999 | CA2308453A1 Method of reducing craving in mammals |
| 05/06/1999 | CA2307891A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | CA2307890A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | CA2307889A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2306905A1 Fatty acid-acylated insulin analogs |
| 05/06/1999 | CA2306877A1 Insoluble insulin compositions |
| 05/06/1999 | CA2306379A1 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye |
| 05/06/1999 | CA2305258A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1215724A Novel compounds |
| 05/05/1999 | CN1215606A Calcium product and raw material thereof, and process of producing thereof |
| 05/04/1999 | US5900436 Therapy for lipid metabolism disorders |
| 05/04/1999 | US5900255 Material for prevention and treatment of osteoporosis |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 05/04/1999 | CA2058619C Process for the preparation of substituted isoflavone derivatives |
| 04/29/1999 | WO1999020755A2 Novel cytokine receptors |
| 04/29/1999 | WO1999020739A2 Novel lactic acid bacteria species |
| 04/29/1999 | WO1999020624A1 Bicyclic kinase inhibitors |
| 04/29/1999 | WO1999020621A1 ARYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS AND 5-HT1Dα ANTAGONISTS |
| 04/29/1999 | WO1999020614A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1999 | WO1999020613A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
| 04/29/1999 | WO1999020607A1 Amide derivatives or salts thereof |
| 04/29/1999 | WO1999020279A1 Potentiation of pharmaceuticals |
| 04/29/1999 | WO1999020277A1 Rapidly soluble drug composition |
| 04/29/1999 | WO1999020275A1 Therapeutic uses of quinoline derivatives |
| 04/29/1999 | WO1999020260A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 04/29/1999 | WO1998058669A3 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 04/29/1999 | DE19747195A1 Compositions for treating diabetic retinopathy |
| 04/29/1999 | DE19747063A1 New 3-substituted tetrahydropyridopyrimidinone derivatives |
| 04/29/1999 | CA2307114A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d.alpha. antagonists |
| 04/29/1999 | CA2306870A1 Bicyclic kinase inhibitors |
| 04/29/1999 | CA2306825A1 Therapeutic uses of quinoline derivatives |
| 04/29/1999 | CA2306233A1 Potentiation of pharmaceuticals |
| 04/29/1999 | CA2305891A1 New species of lactic acid bacterium |
| 04/28/1999 | EP0911342A1 Novel protein and process for producing the same |
| 04/28/1999 | EP0911331A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 04/28/1999 | EP0910960A2 Calcium product and a raw material for the product and processes for their preparation |
| 04/28/1999 | EP0910565A1 Amide derivatives as selective neuropeptide y receptor antagonists |
| 04/28/1999 | EP0910564A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 04/28/1999 | EP0910400A1 Therapies for chronic renal failure |
| 04/28/1999 | EP0910399A1 Stable pharmaceutical composition of bdnf |
| 04/28/1999 | EP0910384A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
| 04/28/1999 | EP0910372A1 Pharmaceutical compositions containing mesembrine and related compounds |
| 04/28/1999 | EP0910369A1 Benzothiophenes, formulations containing same, and methods |
| 04/28/1999 | EP0910351A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 04/28/1999 | EP0655907B1 Use of diacylolycerols for increasing the melanin content in melanocytes |
| 04/28/1999 | EP0650361B1 Compositions for the treatment of arthritis containing phosphonates and nsaids |
| 04/28/1999 | EP0609440B1 Phosphorus-substituted isoprenoid derivative |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215405A Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215311A Diabetic supplement bar |
| 04/27/1999 | US5898033 Antiinflammatory non-immunogenic conjugate comprising polyamino acid backbone having multiplicity of molecules of non-steroidal antiinflammatory agent linked thereto, which is preferentially internalized by antigen-processing cells |
| 04/27/1999 | US5898030 hGH containing pharmaceutical compositions |
| 04/27/1999 | US5897891 Consists of a zinc compound, a mono-carboxylic amino acid, and lesser amount of copper compound; pleasant flavor |
| 04/27/1999 | CA2018085C Alpha-glycosyl hesperidin, and its preparation and uses |
| 04/22/1999 | WO1999019477A1 Cadherin derived growth factor and the application thereof |
| 04/22/1999 | WO1999019354A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | WO1999019342A1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 04/22/1999 | WO1999019325A1 8-azabicyclo [3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018974A1 Use of sulfated oligosaccharides in lowering blood triglyceride levels |
| 04/22/1999 | WO1999018972A1 New improved formulation for treatment of osteoporosis |
| 04/22/1999 | WO1999018945A1 Method of building and maintaining bone |
| 04/22/1999 | WO1999018944A1 Use of thiazolidinediones for the treatment of hyperglycaemia |
| 04/22/1999 | WO1999018943A1 Use of thiazolidinediones for the treatment of hyperglycaemia |
| 04/22/1999 | WO1999018932A1 Novel once-a-day controlled release sulfonylurea formulation |
| 04/22/1999 | WO1999018801A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof |
| 04/22/1999 | WO1999006035A3 COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | CA2306766A1 Use of sulfated oligosaccharides in lowering blood triglyceride levels |
| 04/22/1999 | CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | CA2306344A1 Method of building and maintaining bone |
| 04/22/1999 | CA2306086A1 Use of thiazolidinediones for the treatment of hyperglycaemia |
| 04/22/1999 | CA2306062A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | CA2305289A1 Use of thiazolidinediones for the treatment of hyperglycaemia |
| 04/21/1999 | EP0909768A2 Process for removing bile salts from a patient and alkylated compositions therefor |
| 04/21/1999 | EP0909758A1 Dithiolylidene acetamide derivatives |
| 04/21/1999 | EP0909171A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 04/21/1999 | EP0909132A1 Dietetic foods containing conjugated linoleic acids |
| 04/21/1999 | EP0633261B1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 04/21/1999 | CN1214616A Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acid |
| 04/21/1999 | CN1214339A Pyrazole derivatives, their preparation and their use in pharmaceuticals |
| 04/20/1999 | CA2120290C Process for preparing spherules of active agents |
| 04/17/1999 | CA2250523A1 Dithiolylidene acetamide derivatives |
| 04/15/1999 | WO1999018081A1 Substituted fused heterocyclic compounds |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018070A1 Novel vitamin d analogues |
| 04/15/1999 | WO1999018066A1 Amidocarboxylic acid derivatives |
| 04/15/1999 | WO1999017798A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | WO1999017787A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 04/15/1999 | WO1999017781A1 Osteoblast-specific mitogens and drugs containing such compounds |
| 04/15/1999 | WO1999017778A1 α-KETOAMIDE MULTICATALYTIC PROTEASE INHIBITORS |